West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus
Go back to West Pharma (WST) Tops Q2 EPS by 34c, Revenues Beat; Raises FY20 EPS/Revenue Guidance Above Consensus| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 368.54 +6.76 (1.87%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $361.78 | 52 Week High | $84.33 | |||
| Open | $367.42 | 52 Week Low | $53.88 | |||
| Day High | $369.17 | P/E | 234.74 | |||
| Day Low | $365.26 | EPS | $1.57 | |||
| Volume | 42,204 | |||||
